Plan your marketing strategy with Manufacturing Chemist

Published: 14-Jul-2026
Media Distribution Personal Protection Manufacturing Ingredients Hi Tech Manufacturing Packaging Sustainability Regulatory Drug Delivery Research & Development Analysis Marketing Digital Medical Devices Pharmaceutical Finished Product Cell & Gene Therapy Dosage Forms Pharma 5.0

Discover upcoming special reports, themed features and commercial opportunities to help you connect with pharmaceutical manufacturing decision-makers throughout the year

Plan your marketing strategy with Manufacturing Chemist

Whether you're launching a new technology, promoting a service or looking to strengthen your brand presence, Manufacturing Chemist's calendar is designed to put your business in front of a highly engaged global audience.

Below you'll find our upcoming special projects, industry spotlights and event-focused features, giving you plenty of opportunities to align your marketing with the topics that matter most to pharmaceutical manufacturers. From sponsored content and display advertising to thought leadership and bespoke campaigns, our team can help you maximise your visibility at the right time.

Interested in getting involved? Email chris@hpcimedia.com to enquire for pricing and details.

Upcoming projects

CPHI Milan

  • Exhibitor Pre-Show Newsletters | September 25, 28
  • Booth Interviews | Filming: October 6, 7, 8

Upcoming special focus newsletters

Advanced Therapeutics & Bioprocessing       

We are seeking technical article contributions covering…..

  • Cell & Gene Therapy
  • Viral Vector Manufacturing
  • Next-Gen Modalities                                  
  • Advanced Bioprocessing
  • Advanced Therapy Scale-up

Pharma 4.0 & The Smart Factory

We are seeking technical article contributions covering…..

  • AI, Machine Learning, & "Lights Out" Automation
  • Digital Twins & The "Digital Thread"
  • Industry 5.0 & Cognitive Manufacturing
  • Analytical & Process Analytical Technologies
  • Digital Compliance Platforms

OSD & Processing Innovation

We are seeking technical article contributions covering…..

  • OSD & Continuous Processing
  • Advanced Solid Dosage Design (TiC & Multi-Layer Tableting)
  • Sterile Manufacturing, Fill-Finish, & Lyophilisation
  • Containment Technologies & HPAPI Processing
  • Automated Coating & QbD Analytics

Outsourcing & Supply Chain

We are seeking technical article contributions covering…..

  • Strategic CDMO Co-Development Partnerships
  • The Pure-Play CDMO Transition
  • Supply Chain Resilience, Sustainability, & Domestic Capacity
  • Cold Chain Logistics & Smart Packaging
  • Sterile Fill-Finish & Drug-Device Combinations

Interested in taking part in one of our upcoming projects?

The team will be happy to discuss the opportunities available and recommend the most effective package for your objectives, budget and target audience.

Get in touch and email chris@hpcimedia.com to secure your place in an upcoming feature and start planning your marketing campaign with Manufacturing Chemist.

See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Sustainability
ESG: transforming the pharmaceutical supply chain

ESG: transforming the pharmaceutical supply chain

Read more
As pharmaceutical businesses place greater scrutiny on the environmental performance of their supply chains, manufacturers are under growing pressure to show that sustainability is embedded in the way they operate

Trending Articles

  1. Sanofi offers EU commitments for flu vaccine disparagement claims Sanofi has proposed remedies to EU antitrust regulators after allegations it disparaged rival CSL Seqirus's Fluad vaccine in Germany and France since 2024
  2. Teva and Polpharma Biologics sign global licensing deal for Ocrevus biosimilar candidate The agreement will expand Teva’s biosimilars pipeline, with the company securing exclusive commercialisation rights for Polpharma Biologics’ proposed ocrelizumab biosimilar across key global markets

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Sustainability
ESG: transforming the pharmaceutical supply chain

ESG: transforming the pharmaceutical supply chain

As pharmaceutical businesses place greater scrutiny on the environmental performance of their supply chains, manufacturers are under growing pressure to show that sustainability is embedded in the way they operate
Digital
Insilico Medicine and CMS deepen AI drug discovery tie-up with new CNS collaboration

Insilico Medicine and CMS deepen AI drug discovery tie-up with new CNS collaboration

The AI-driven biotech and China Medical System have struck a second collaboration in three months, targeting a mass-market CNS indication via a novel mechanism identified by Insilico's PandaOmics platform
Research & Development
Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

The global study builds on US POINTER trial findings, testing whether adding a metabolism-targeting drug to structured lifestyle programmes can further reduce cognitive decline risk in at-risk older adults during a three-year period
Manufacturing
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

Piramal Pharma Limited (PPL) (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global platform, investing in differentiated capabilities, advancing sustainability, and delivering quality across operations
Manufacturing
WuXi Biologics' Hebei facility secures FDA PLI approval for commercial autoimmune biologics manufacturing

WuXi Biologics' Hebei facility secures FDA PLI approval for commercial autoimmune biologics manufacturing

The FDA's pre-licence inspection approval of WuXi Biologics' MFG8 facility will strengthen the CRDMO's commercial manufacturing network, supporting the global supply of a potential blockbuster autoimmune therapy
Manufacturing
Boehringer Ingelheim standardises plant maintenance globally with osapiens

Boehringer Ingelheim standardises plant maintenance globally with osapiens

Boehringer Ingelheim has selected the osapiens HUB for Mobile Maintenance for its global, regulated manufacturing operations
Manufacturing
Brabender TwinLab B-TSE-S 30/40: Pilot-scale extrusion with lab-level insight

Brabender TwinLab B-TSE-S 30/40: Pilot-scale extrusion with lab-level insight

With throughput up to 100 kg/h, the new twin-screw extruder brings lab-grade process understanding into pilot-scale production, enabling users to validate process parameters and produce relevant quantities under realistic conditions
Subscribe now